Back to Search Start Over

Cargo Therapeutics prepares IPO to carry CAR-T through phase 2 trials.

Authors :
Waldron, James
Source :
FierceBiotech; 10/23/2023, pN.PAG-N.PAG, 1p
Publication Year :
2023

Abstract

If it wasn't enough for Cargo to raise $200 million and recruit a C-suite of biopharma veterans this year, the CAR-T-focused company is eying an IPO. [ABSTRACT FROM AUTHOR]

Subjects

Subjects :
GOING public (Securities)
FREIGHT & freightage

Details

Language :
English
Database :
Complementary Index
Journal :
FierceBiotech
Publication Type :
Periodical
Accession number :
173178958

Tools

Authors Abstract Subjects Details